FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rajender Reddy

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Hepacivirus

Procedures

Concepts & Ideas

Anatomy

Livers

Physiology

Genotype

Co-author Network

Publications

TOP 3
Eric J Lawitz; Alessandra Mangia; John G McHutchison; John McNally; Lisa Nyberg; K Rajender Reddy; Maribel Rodriguez-Torres; Michael Schultz; Aasim M Sheikh; G. SUBRAMANIAN; William T Symonds; David Wyles; Zobair Younossi; Sarah Arterburn; Diana Brainard; Mitchell N Davis; Stuart C Gordon; Tarek Hassanein; Robert H Hyland; Ira M Jacobson; Deyuan Jiang; Zeid Kayali; Kris V Kowdley; Edward J Gane
Sofosbuvir for previously untreated chronic hepatitis C infection.
Eric J Lawitz; Ming Lin; Michael Mader; Hongmei Mo; David R Nelson; F Fred Poordad; K Rajender Reddy; Maribel Rodriguez-Torres; Aasim M Sheikh; Mark S Sulkowski; William T Symonds; Gary A Abrams; Nezam H Afdhal; Efsevia Albanis; David E Bernstein; Michelle M Berrey; Natalie H Bzowej; Jama M Darling; Edwin Dejesus; Douglas T Dieterich; Bradley Freilich; Tarek Hassanein; Robert Hindes; Robert H Hyland; Ira M Jacobson; Donald Jensen; Kris V Kowdley; Jay P Lalezari; Andrew Muir
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
K Rajender Reddy; C Bunchorntavakul
Letter: retrospective reviews of liver-related case reports allegedly associated with Herbalife present insufficient and inaccurate data--authors' reply.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rajender Reddy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eric J Lawitz; Alessandra Mangia; John G McHutchison; John McNally; Lisa Nyberg; K Rajender Reddy; Maribel Rodriguez-Torres; Michael Schultz; Aasim M Sheikh; G. SUBRAMANIAN; William T Symonds; David Wyles; Zobair Younossi; Sarah Arterburn; Diana Brainard; Mitchell N Davis; Stuart C Gordon; Tarek Hassanein; Robert H Hyland; Ira M Jacobson; Deyuan Jiang; Zeid Kayali; Kris V Kowdley; Edward J Gane
Sofosbuvir for previously untreated chronic hepatitis C infection.
The New England journal of medicine 2013;368(20):1878-87.
2013: Eric J Lawitz; Ming Lin; Michael Mader; Hongmei Mo; David R Nelson; F Fred Poordad; K Rajender Reddy; Maribel Rodriguez-Torres; Aasim M Sheikh; Mark S Sulkowski; William T Symonds; Gary A Abrams; Nezam H Afdhal; Efsevia Albanis; David E Bernstein; Michelle M Berrey; Natalie H Bzowej; Jama M Darling; Edwin Dejesus; Douglas T Dieterich; Bradley Freilich; Tarek Hassanein; Robert Hindes; Robert H Hyland; Ira M Jacobson; Donald Jensen; Kris V Kowdley; Jay P Lalezari; Andrew Muir
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.
The Lancet infectious diseases 2013;13(5):401-8.
2013: K Rajender Reddy; C Bunchorntavakul
Letter: retrospective reviews of liver-related case reports allegedly associated with Herbalife present insufficient and inaccurate data--authors' reply.
Alimentary pharmacology & therapeutics 2013;37(7):754-5.
2013: David Alan Herbst; K Rajender Reddy
Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection.
Expert opinion on investigational drugs 2013;22(4):527-36.
2013: Ming Valerie Lin; K Rajender Reddy; Wojciech Blonski; Anna M Buchner; Gary R Lichtenstein
The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease.
Digestive diseases and sciences 2013;58(4):1149-56.
2013: David S Goldberg; Alvaro Martinez-Camacho; Amanda Camp; Lisa Forman; Brett Fortune; K Rajender Reddy
Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013;19(3):250-8.
2013: Stephen A Harrison; Wlodzimierz Mazur; Michael McKenna; Diethelm Messinger; K Rajender Reddy; Maribel Rodriguez-Torres; Mitchell L Shiffman; Giovanni Faria Silva; Fernando Tatsch; Djamal Abdurakhmanov; Igor Bakulin; Hugo Cheinquer; Edward V Connell
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
Journal of clinical gastroenterology 2013;47(3):271-9.
2013: C Bunchorntavakul; K Rajender Reddy
Review article: herbal and dietary supplement hepatotoxicity.
Alimentary pharmacology & therapeutics 2013;37(1):3-17.
2012: Jasmohan S Bajaj; Geri Brown; Patrick S Kamath; Nicole A Noble; Jacqueline G O'Leary; Jody C Olson; K Rajender Reddy; Ram M Subramanian; Leroy R Thacker; Florence Wong
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.
Hepatology (Baltimore, Md.) 2012;56(6):2328-35.
2012: Patrick Marcellin; Diethelm Messinger; K Rajender Reddy; Moises Diago; Stephanos Hadziyannis; Stephen A Harrison; Donald M Jensen; Stuart K Roberts; Fernando Tatsch; Martin Weltman; Mario Rizzetto
Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies.
Expert opinion on drug safety 2012;11(6):901-9.
2012: Vincent Lo Re; David Margolis; Eileen E Ming; Hanieh Razzaghi; K Rajender Reddy; Peter P Reese; Jason Roy; Andrea Apter; Harshvinder Bhullar; Dena M Carbonari; Serena Cardillo; Daina B Esposito; Kimberly Fortier; Cristin P Freeman; Kevin Haynes; Sean Hennessy; Crystal N Holick; Laura N Horne; Stephen E Kimmel; Tjeerd-Pieter Van Staa; Jennifer Wood Ives; Brian L Strom
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies.
Pharmacoepidemiology and drug safety 2012;21(11):1202-15.
2012: Raymond T Chung; Robert J Fontana; Wajahat Z Mehal; K Rajender Reddy; Frank V Schiodt; R Todd Stravitz; William M Lee
Pathogenesis of liver injury in acute liver failure.
Gastroenterology 2012;143(3):e1-7.
2012: Calvin Q Pan; Gaurav Singhvi; Chalermrat Bunchorntavakul; Marc G Ghany; William M Huang; Jeffrey Karsdon; Li-Jun Mi; K Rajender Reddy
Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series.
Digestive diseases and sciences 2012;57(9):2423-9.
2012: Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Patrick S Kamath
Bacterial infections in end-stage liver disease: current challenges and future directions.
Gut 2012;61(8):1219-25.
2012: Michael W Fried; Roy L Hawke; Catherine M Meyers; Victor J Navarro; K Rajender Reddy; Abdus Wahed; Nezam H Afdhal; Steven H Belle; Edward Doo
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2012;308(3):274-82.
2012: G Sathish Kumar; Bartholomäus Pieber; K Rajender Reddy; C Oliver Kappe
Copper-catalyzed formation of C-O bonds by direct α-C-H bond activation of ethers using stoichiometric amounts of peroxide in batch and continuous-flow formats.
Chemistry (Weinheim an der Bergstrasse, Germany) 2012;18(20):6124-8.
2012: Chalermrat Bunchorntavakul; K Rajender Reddy
Pruritus in chronic cholestatic liver disease.
Clinics in liver disease 2012;16(2):331-46.
2012: Ira M Jacobson; Paul Y Kwo; F Fred Poordad; K Rajender Reddy; R S Brown; Eugene R Schiff
Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations.
Journal of viral hepatitis 2012;19(4):236-43.
2012: C Q Pan; C Bunchorntavakul; W Chen; K-Q Hu; A S Yu; K Rajender Reddy
Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir.
Journal of viral hepatitis 2012;19(3):213-9.
2012: K Rajender Reddy; Abdus Wahed; Nezam Afdhal; Steven H Belle; Edward Doo; Michael W Fried; Roy L Hawke; Catherine M Meyers; Victor J Navarro
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C.
Clinical trials (London, England) 2012;9(1):102-12.
2011: G Sathish Kumar; R Arun Kumar; C Uma Maheswari; M Lakshmi Kantam; K Rajender Reddy
Copper-catalyzed oxidative C-O coupling by direct C-H bond activation of formamides: synthesis of enol carbamates and 2-carbonyl-substituted phenol carbamates.
Angewandte Chemie (International ed. in English) 2011;50(49):11748-51.
2011: Sarah J Schrieber; Philip C Smith; Abdus Wahed; Zhiming Wen; Nezam H Afdhal; Steven H Belle; Edward Doo; Roy L Hawke; Catherine M Meyers; Victor J Navarro; K Rajender Reddy; Michael W Fried
Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.
Drug metabolism and disposition: the biological fate of chemicals 2011;39(12):2182-90.
2011: David Goldberg; K Rajender Reddy; Arwin Thomasson; Benjamin French; Scott D Halpern
Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2011;17(11):1355-63.
2011: Ranjeeta Bahirwani; Meenakshi Bewtra; Kimberly Forde; Oren Shaked; K Rajender Reddy
Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes.
Transplantation 2011;92(8):952-7.
2011: C Bunchorntavakul; D Drazek; E E Furth; K Olthoff; A Shaked; E S Siegelman; M C Soulen; R Bahirwani; K Rajender Reddy
Clinical features and natural history of hepatocellular adenomas: the impact of obesity.
Alimentary pharmacology & therapeutics 2011;34(6):664-74.
2011: Alexander R Bonnel; Chalermrat Bunchorntavakul; K Rajender Reddy
Immune dysfunction and infections in patients with cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(9):727-38.
2011: Vincent Lo Re; K Rajender Reddy; David Rimland; Maria C Rodriguez-Barradas; Janet Tate; Farah Kidwai; Marina B Klein; Joseph K Lim; Harini Bathulapalli; Cynthia Brandt; Sheldon T Brown; Adeel A Butt; Zachariah Dorey-Stein; Cynthia L Gibert; Matthew Bidwell Goetz; Amy C Justice
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study.
Pharmacoepidemiology and drug safety 2011;20(7):689-99.
2011: Oren Shaked; Evan S Siegelman; Kim Olthoff; K Rajender Reddy
Biologic and clinical features of benign solid and cystic lesions of the liver.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(7):547-62.e1-4.
2011: Ira M Jacobson; Robert S Kauffman; Tara L Kieffer; Patrick Marcellin; John G McHutchison; Andrew J Muir; K Rajender Reddy; Mario Rizzetto; Abdul J Sankoh; Daniel Shouval; Ricard Sola; Ruben A Terg; Eric M Yoshida; Stefan Zeuzem; Nathalie Adda; Leif Bengtsson; Natalie H Bzowej; Adrian M Di Bisceglie; Geoffrey Dusheiko; Peter Ferenci; Robert Flisiak; Jacob George; Shelley George
Telaprevir for previously untreated chronic hepatitis C virus infection.
The New England journal of medicine 2011;364(25):2405-16.
2011: Ranjeeta Bahirwani; Oren Shaked; Shanu Kurd; Roy Bloom; K Rajender Reddy
Chronic kidney disease after orthotopic liver transplantation: impact of hepatitis C infection.
Transplantation 2011;91(11):1245-9.
2011: David Roth; Jeffrey J Gaynor; K Rajender Reddy; Gaetano Ciancio; Junichiro Sageshima; Warren Kupin; Giselle Guerra; Linda Chen; George W Burke
Effect of kidney transplantation on outcomes among patients with hepatitis C.
Journal of the American Society of Nephrology : JASN 2011;22(6):1152-60.
2011: Chalermrat Bunchorntavakul; K Rajender Reddy
Donation after cardiac death organs for patients with hepatitis C virus: are we rolling the dice, or are they just as good as any?
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2011;17(6):625-7.
2011: David Seth Goldberg; Benjamin French; Arwin Thomasson; K Rajender Reddy; Scott D Halpern
Current trends in living donor liver transplantation for primary sclerosing cholangitis.
Transplantation 2011;91(10):1148-52.
2011: F Fred Poordad; Jonathan McCone; Bruce R Bacon; Savino Bruno; Michael P Manns; Mark S Sulkowski; Ira M Jacobson; K Rajender Reddy; Zachary D Goodman; Navdeep Boparai; Mark J DiNubile; Vilma Sniukiene; Clifford A Brass; Janice K Albrecht; Jean-Pierre Bronowicki
Boceprevir for untreated chronic HCV genotype 1 infection.
The New England journal of medicine 2011;364(13):1195-206.
2011: Manuel Mendizabal; K Rajender Reddy; James Cassuto; Kim M Olthoff; Thomas W Faust; George A Makar; Elizabeth B Rand; Abraham Shaked; Peter L Abt
Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2011;17(3):243-50.
2011: Kimberly A Forde; K Rajender Reddy
Hormones: a potential explanation for differences in response rates to therapy for chronic hepatitis C infection.
Gastroenterology 2011;140(3):776-9.
2011: Steven-Huy Han; K Rajender Reddy; Emmet B Keeffe; Consuelo Soldevila-Pico; Robert Gish; Raymond T Chung; Bulent Degertekin; Anna S F Lok
Clinical outcomes of liver transplantation for HBV-related hepatocellular carcinoma: data from the NIH HBV OLT study.
Clinical transplantation 2011;25(2):E152-62.
2010: K Rajender Reddy; Mitchell L Shiffman; Maribel Rodriguez-Torres; Hugo Cheinquer; Djamal Abdurakhmanov; Igor Bakulin; Viacheslav Morozov; Giovanni Faria Silva; Natalia Geyvandova; Carol Stanciu; Michael Rabbia; Michael McKenna; James A Thommes; Stephen A Harrison
Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads.
Gastroenterology 2010;139(6):1972-83.
2010: Mark S Sulkowski; Mitchell L Shiffman; Nezam H Afdhal; K Rajender Reddy; Jonathan McCone; William M Lee; Steven K Herrine; Stephen A Harrison; F Fred Poordad; Kenneth Koury; Weiping Deng; Stephanie Noviello; Lisa Pedicone; Clifford A Brass; Janice K Albrecht; John G McHutchison
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
Gastroenterology 2010;139(5):1602-11, 1611.e1.
2010: Roy L Hawke; Sarah J Schrieber; Tedi A Soule; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Josh Berman; Qi-Ying Liu; Edward Doo; Michael W Fried
Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C.
Journal of clinical pharmacology 2010;50(4):434-49.
2010: Zina Meriden; Kimberly A Forde; Theresa L Pasha; Jia-Ji Hui; K Rajender Reddy; Emma E Furth; Rebecca G Wells
Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2010;8(3):289-96, 296.e1-8.
2009: Manuel Mendizabal; Terina Chen; K Rajender Reddy
Jaundice after allogeneic hematopoietic stem cell transplantation.
Hepatology (Baltimore, Md.) 2009;50(6):2044-5.
2009: Ranjeeta Bahirwani; K Rajender Reddy
Outcomes after liver transplantation: chronic kidney disease.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15 Suppl 2():S70-4.
2009: Manuel Mendizabal; Soledad Craviotto; Terina Chen; Marcelo O Silva; K Rajender Reddy
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
Annals of hepatology 2009;8(4):390-5.
2009: Kimberly A Forde; K Rajender Reddy; Andrea B Troxel; Corron M Sanders; William M Lee
Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(10):1121-6.
2009: K Rajender Reddy; D Messinger; M Popescu; Stephanos J Hadziyannis
Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients.
Journal of viral hepatitis 2009;16(10):724-31.
2009: Kimberly A Forde; K Rajender Reddy
Hepatitis C virus infection and immunomodulatory therapies.
Clinics in liver disease 2009;13(3):391-401.
2009: Manuel Mendizabal; K Rajender Reddy
Current management of hepatocellular carcinoma.
The Medical clinics of North America 2009;93(4):885-900, viii.
2009: Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S F Lok; Paul D Wagner; sudhir srivastava; Myron Schwartz
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
Gastroenterology 2009;137(1):110-8.
2009: Oren Shaked; K Rajender Reddy
Approach to a liver mass.
Clinics in liver disease 2009;13(2):193-210.
2009: Donald M Jensen; Patrick Marcellin; Bradley Freilich; Pietro Andreone; Adrian Di Bisceglie; Carlos E Brandão-Mello; K Rajender Reddy; Antonio Craxi; Antonio Olveira Martin; Gerlinde Teuber; Diethelm Messinger; James A Thommes; Andreas Tietz
Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial.
Annals of internal medicine 2009;150(8):528-40.
2009: J de Jonge; S Kurian; Abraham Shaked; K Rajender Reddy; W Hancock; D R Salomon; Kim M Olthoff
Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(4):758-72.
2009: K Rajender Reddy; David R Nelson; Stefan Zeuzem
Ribavirin: current role in the optimal clinical management of chronic hepatitis C.
Journal of hepatology 2009;50(2):402-11.
2009: Richard K Sterling; Lennox Jeffers; Fredric Gordon; Alan P Venook; K Rajender Reddy; Shinji Satomura; Futoshi Kanke; Myron E Schwartz; Morris Sherman
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(1):104-13.
2008: R Bahirwani; K Rajender Reddy
Review article: the evaluation of solitary liver masses.
Alimentary pharmacology & therapeutics 2008;28(8):953-65.
2008: T-M Scherzer; K Rajender Reddy; F Wrba; Harald Hofer; K Staufer; Petra Steindl-Munda; Alfred Gangl; Peter Ferenci
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C.
Journal of viral hepatitis 2008;15(9):659-65.
2008: Wojciech Blonski; K Rajender Reddy
Hepatitis C virus infection and hepatocellular carcinoma.
Clinics in liver disease 2008;12(3):661-74, x.
2008: K Rajender Reddy; David Edward Kaplan
Hepatitis C virus. Preface.
Clinics in liver disease 2008;12(3):xiii-xiv.
2008: Hashem B El-Serag; Jorge A Marrero; Lenhard Rudolph; K Rajender Reddy
Diagnosis and treatment of hepatocellular carcinoma.
Gastroenterology 2008;134(6):1752-63.
2008: Ranjeeta Bahirwani; Mical S Campbell; Tim Siropaides; James F Markmann; Kim M Olthoff; Abraham Shaked; Roy D Bloom; K Rajender Reddy
Transplantation: impact of pretransplant renal insufficiency.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(5):665-71.
2008: Kim M Olthoff; K Rajender Reddy
First, do no harm: The question of liver biopsy in living liver donors.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(4):420-2.
2008: Patrick Marcellin; George K K Lau; Stefan Zeuzem; E Jenny Heathcote; Paul J Pockros; K Rajender Reddy; Teerha Piratvisuth; Patrizia Farci; Wan-Cheng Chow; Ji-Dong Jia; Woon Paik; Neil Wintfeld; Nigel Pluck
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(4):477-85.
2008: Kirti Shetty; Munira Hussain; Lei Nei; K Rajender Reddy; Anna S F Lok
Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(4):534-40.
2008: K Rajender Reddy; S Govindarajan; P Marcellin; D Bernstein; J L Dienstag; Henry Jr. Bodenheimer; J Rakela; D Messinger; G Schmidt; A Ackrill; Stephanos J Hadziyannis
Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.
Journal of viral hepatitis 2008;15(2):129-36.
2008: Mical S Campbell; Keith Obstein; K Rajender Reddy; Yu-Xiao Yang
Association between proton pump inhibitor use and spontaneous bacterial peritonitis.
Digestive diseases and sciences 2008;53(2):394-8.
2008: Geoffrey Dusheiko; David Nelson; K Rajender Reddy
Ribavirin considerations in treatment optimization.
Antiviral therapy 2008;13 Suppl 1():23-30.
2008: Fred Poordad; K Rajender Reddy; Paul Martin
Rapid virologic response: a new milestone in the management of chronic hepatitis C.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(1):78-84.
2008: Patrick G Northup; Vinay Sundaram; M B Fallon; K Rajender Reddy; Rasheed A Balogun; Arun J Sanyal; Q M Anstee; M R Hoffman; Y Ikura; Stephen H Caldwell
Hypercoagulation and thrombophilia in liver disease.
Journal of thrombosis and haemostasis : JTH 2008;6(1):2-9.
2007: Wojciech Blonski; Timothy Siropaides; K Rajender Reddy
Coagulopathy in liver disease.
Current treatment options in gastroenterology 2007;10(6):464-73.
2007: Anna E Rutherford; Linda Hynan; Carolina B S Borges; David G Forcione; Jason T Blackard; Wenyu Lin; April R Gorman; Obaid Shakil Shaikh; Adrian Reuben; Edwyn Harrison; K Rajender Reddy; William M Le; Raymond T Chung
Serum apoptosis markers in acute liver failure: a pilot study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(12):1477-83.
2007: Wojciech Blonski; Arie Regev; K Rajender Reddy
Laparoscopic observations of the liver in hereditary hemorrhagic telangiectasia.
Scandinavian journal of gastroenterology 2007;42(12):1512-3.
2007: Keith L Obstein; Mical S Campbell; K Rajender Reddy; Yu-Xiao Yang
Association between model for end-stage liver disease and spontaneous bacterial peritonitis.
The American journal of gastroenterology 2007;102(12):2732-6.
2007: Richard K Sterling; Lennox Jeffers; Fredric Gordon; Morris Sherman; Alan P Venook; K Rajender Reddy; Shinji Satomura; Myron E Schwartz
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
The American journal of gastroenterology 2007;102(10):2196-205.
2007: Mical S Campbell; Serban Constantinescu; Emma E Furth; K Rajender Reddy; Roy D Bloom
Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates.
Digestive diseases and sciences 2007;52(10):2501-7.
2007: Richard Peek; K Rajender Reddy
Hepatitis C virus-infected donors in liver transplantation.
Gastroenterology 2007;133(2):381-2.
2007: Richard Peek; K Rajender Reddy
Doctor Griffin Rodgers at helm of the National Institute of Diabetes and Digestive and Kidney Diseases.
Gastroenterology 2007;133(2):380-1.
2007: Richard Peek; K Rajender Reddy
Folic Acid supplements do not appear to reduce risk of colorectal tumors.
Gastroenterology 2007;133(2):379.
2007: Richard Peek; K Rajender Reddy
Genetic mutations identified for hereditary diffuse gastric cancer.
Gastroenterology 2007;133(2):379-80.
2007: Alan D Enriquez; Mical S Campbell; K Rajender Reddy
Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis.
Alimentary pharmacology & therapeutics 2007;26(3):383-91.
2007: Maria H Sjogren; Robert Sjogren; Michael F Lyons; Michael Ryan; John Santoro; Coleman Smith; K Rajender Reddy; Herbert Bonkovsky; Brooke Huntley; Sima Faris-Young
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Digestive diseases and sciences 2007;52(6):1540-7.
2007: John G McHutchison; Michael P Manns; Robert S Brown; K Rajender Reddy; Mitchell L Shiffman; John Wong
Strategies for managing anemia in hepatitis C patients undergoing antiviral therapy.
The American journal of gastroenterology 2007;102(4):880-9.
2007: Paul J Pockros; Lennox Jeffers; Nezam H Afdhal; Zachary D Goodman; David Nelson; Robert G Gish; K Rajender Reddy; Robert W Reindollar; Maribel Rodriguez-Torres; Sarah Sullivan; Lawrence M Blatt; Sima Faris-Young
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
Hepatology (Baltimore, Md.) 2007;45(3):569-78.
2007: Vincent Lo Re; Jay R Kostman; Robert Gross; K Rajender Reddy; Karam Mounzer; Babette S Zemel; Hanna Rennert; Donald D Stieritz; Mary E Putt; Ian Frank; Brian L Strom
Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy.
Journal of acquired immune deficiency syndromes (1999) 2007;44(3):344-50.
2007: Stephen N Wong; K Rajender Reddy; Emmet B Keeffe; Steven-Huy Han; Paul Gaglio; Robert P Perrillo; Tram T Tran; Timothy L Pruett; Anna S F Lok
Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(3):334-42.
2007: David Edward Kaplan; Kazushi Sugimoto; Kimberly Newton; Mary E Valiga; Fusao Ikeda; Ayse Aytaman; Frederick A Nunes; Michael R Lucey; Barbara A Vance; Robert H Vonderheide; K Rajender Reddy; Jane A McKeating; Kyong-Mi Chang
Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.
Gastroenterology 2007;132(2):654-66.
2007: K Rajender Reddy; Mitchell L Shiffman; Timothy R Morgan; Stefan Zeuzem; Stephanos Hadziyannis; Fayez M Hamzeh; Teresa L Wright; Michael W Fried
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(1):124-9.
2007: Norah A Terrault; Mitchell L Shiffman; Anna S F Lok; Sammy Saab; Lan Tong; Robert S Brown; Gregory T Everson; K Rajender Reddy; Jeffrey Fair; Laura M Kulik; Timothy L Pruett; Leonard B Seeff
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(1):122-9.
2006: Stephen H Caldwell; Maureane Hoffman; Ton Lisman; B Gail Macik; Patrick G Northup; K Rajender Reddy; Armando Tripodi; Arun J Sanyal
Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management.
Hepatology (Baltimore, Md.) 2006;44(4):1039-46.
2006: Charles D Howell; Lennox Jeffers; William Cassidy; K Rajender Reddy; S Hu; J S Lee
Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response.
Journal of viral hepatitis 2006;13(6):371-6.
2006: David S Kotlyar; Mical S Campbell; K Rajender Reddy
Recurrence of diseases following orthotopic liver transplantation.
The American journal of gastroenterology 2006;101(6):1370-8.
2006: Donald M Jensen; Timothy R Morgan; Patrick Marcellin; Paul J Pockros; K Rajender Reddy; Stephanos J Hadziyannis; Peter Ferenci; Andrew M Ackrill; Bernard Willems
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy.
Hepatology (Baltimore, Md.) 2006;43(5):954-60.
2006: Nathan A Merriman; Steven B Porter; Colleen Brensinger; K Rajender Reddy; Kyong-Mi Chang
Racial difference in mortality among U.S. veterans with HCV/HIV coinfection.
The American journal of gastroenterology 2006;101(4):760-7.
2006: Paige M Porrett; Heather Peterman; Mark Rosen; Seema S Sonnad; Michael C Soulen; James F Markmann; Abraham Shaked; Emma E Furth; K Rajender Reddy; Kim M Olthoff
Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(4):665-73.
2006: Wojciech Blonski; K Rajender Reddy
Evaluation of nonmalignant liver masses.
Current gastroenterology reports 2006;8(1):38-45.
2006: Maxim Itkin; Scott O Trerotola; S William Stavropoulos; Aalpen Patel; Jeffrey I Mondschein; Michael C Soulen; Catherine M Tuite; Richard D Shlansky-Goldberg; Thomas W Faust; K Rajender Reddy; Jeffrey A Solomon; Timothy W I Clark
Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
Journal of vascular and interventional radiology : JVIR 2006;17(1):55-62.
2006: Rolland C Dickson; Norah A Terrault; Michael B Ishitani; K Rajender Reddy; Patricia Sheiner; Velimir A Luketic; Consuelo Soldevila-Pico; Michael Fried; Donald Jensen; Robert S Brown; Gary Horwith; Richard Brundage; Anna S F Lok
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(1):124-33.
2005: Wojciech C Blonski; K Rajender Reddy; Abraham Shaked; Evan S Siegelman; David C Metz
Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature.
World journal of gastroenterology : WJG 2005;11(48):7676-83.
2005: Guy W Neff; Norah Shire; Phillip Ruiz; Christopher B O'Brien; Monica Garcia; J Dela Garza; S R Rudich; K Rajender Reddy
The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
Transplantation proceedings 2005;37(10):4397-402.
2005: Aaron Shields; K Rajender Reddy
Hepatocellular carcinoma: current treatment strategies.
Current treatment options in gastroenterology 2005;8(6):457-66.
2005: Mical S Campbell; David S Kotlyar; Colleen Brensinger; James D Lewis; Kirti Shetty; Roy D Bloom; James F Markmann; Kim M Olthoff; Abraham Shaked; K Rajender Reddy
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(9):1048-55.
2005: Mical S Campbell; Colleen Brensinger; Arun J Sanyal; Chris Gennings; Florence Wong; Kris V Kowdley; Timothy M McCashland; K Rajender Reddy
Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy.
Hepatology (Baltimore, Md.) 2005;42(3):635-40.
2005: Peter Ferenci; Michael W Fried; Mitchell L Shiffman; Coleman I Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moisés Diago; Giampero Carosi; Daniel Dhumeaux; Antonio Craxì; Monique Chaneac; K Rajender Reddy
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.
Journal of hepatology 2005;43(3):425-33.
2005: David Edward Kaplan; Kazushi Sugimoto; Fusao Ikeda; Jason Stadanlick; Mary Valiga; Kirti Shetty; K Rajender Reddy; Kyong-Mi Chang
T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.
Hepatology (Baltimore, Md.) 2005;41(6):1365-75.
2005: Shengyuan Luo; William Cassidy; Lennox Jeffers; K Rajender Reddy; Christine Bruno; Charles D Howell
Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(5):499-506.
2005: Robert G Gish; Nezam H Afdhal; Douglas T Dieterich; K Rajender Reddy
Management of hepatitis C virus in special populations: patient and treatment considerations.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(4):311-8.
2005: Mical Campbell; Yu-Xiao Yang; K Rajender Reddy
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.
Hepatology (Baltimore, Md.) 2005;41(4):939; author reply 939-40.
2005: Roy D Bloom; Gabriel Sayer; Kosunarty Fa; Serban Constantinescu; Peter Abt; K Rajender Reddy
Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(1):139-44.
2005: Scott J Weston; Rachel L Leistikow; K Rajender Reddy; Maria Torres; Anne M Wertheimer; David M Lewinsohn; Sunwen Chou; Michael P Davey; Christopher L Corless; Cliona O'Farrelly; David R Nelson; Hugo Rosen
Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
Hepatology (Baltimore, Md.) 2005;41(1):72-81.
2004: Guy W Neff; K Rajender Reddy; Francisco Durazo; Douglas Meyer; Ricardo Marrero; Neil Kaplowitz
Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid.
Journal of hepatology 2004;41(6):1062-4.
2004: Stefan Zeuzem; Moisés Diago; Edward Gane; K Rajender Reddy; Paul J Pockros; Daniele Prati; Mitchell Shiffman; Patrizia Farci; Norman Gitlin; Christopher B O'Brien; François Lamour; Pilar Lardelli
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.
Gastroenterology 2004;127(6):1724-32.
2004: Barbara A Piasecki; James D Lewis; K Rajender Reddy; Scarlett Bellamy; Steven B Porter; Robert M Weinrieb; Donald D Stieritz; Kyong-Mi Chang
Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population.
Hepatology (Baltimore, Md.) 2004;40(4):892-9.
2004: Mical S Campbell; K Rajender Reddy
Review article: the evolving role of liver biopsy.
Alimentary pharmacology & therapeutics 2004;20(3):249-59.
2004: Peter Abt; Kevin C Mange; Kim M Olthoff; James F Markmann; K Rajender Reddy; Abraham Shaked
Allograft survival following adult-to-adult living donor liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(8):1302-7.
2004: Kirti Shetty; Kate Timmins; Colleen Brensinger; Emma E Furth; Sushil Rattan; Weijing Sun; Mark Rosen; Michael C Soulen; Abraham Shaked; K Rajender Reddy; Kim M Olthoff
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(7):911-8.
2004: Paul J Pockros; Robert L Carithers; Paul Desmond; Daniel Dhumeaux; Michael W Fried; Patrick Marcellin; Mitchell L Shiffman; Gerald Y Minuk; K Rajender Reddy; Robert W Reindollar; Amy Lin; Michael J Brunda
Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial.
The American journal of gastroenterology 2004;99(7):1298-305.
2004: Janak N Shah; Nuzhat A Ahmad; Kirti Shetty; Michael L Kochman; William B Long; Colleen Brensinger; Patrick R Pfau; Kim M Olthoff; James F Markmann; Abraham Shaked; K Rajender Reddy; Gregory G Ginsberg
Endoscopic management of biliary complications after adult living donor liver transplantation.
The American journal of gastroenterology 2004;99(7):1291-5.
2004: Lennox Jeffers; William Cassidy; Charles D Howell; Sylvia Hu; K Rajender Reddy
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.
Hepatology (Baltimore, Md.) 2004;39(6):1702-8.
2004: K Rajender Reddy
Hepatitis C with normal liver enzymes: to treat or not to treat. Con: most patients should not be treated.
The American journal of gastroenterology 2004;99(6):973-5.
2004: Noriyo Yamashiki; Jeffrey J Gaynor; Tomoaki Kato; K Rajender Reddy; Abhasnee Sobhonslidsuk; David M Levi; Seigo Nishida; Juan Madariaga; Jose Nery; Eugene R Schiff; Andreas G Tzakis
Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(5):774-81.
2004: Thomas W Faust; K Rajender Reddy
Postoperative jaundice.
Clinics in liver disease 2004;8(1):151-66.
2004: K Rajender Reddy
Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).
Seminars in liver disease 2004;24 Suppl 2():33-8.
2003: David Edward Kaplan; K Rajender Reddy
Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes.
Clinics in liver disease 2003;7(3):683-714.
2003: Steven B Porter; K Rajender Reddy
Factors that influence the severity of recurrent hepatitis C virus following liver transplantation.
Clinics in liver disease 2003;7(3):603-14.
2003: Javier Parra; K Rajender Reddy
Hepatotoxicity of hypolipidemic drugs.
Clinics in liver disease 2003;7(2):415-33.
2003: Mitchell L Shiffman; Andrea Ferreira-Gonzalez; K Rajender Reddy; Richard K Sterling; Velimir A Luketic; R Todd Stravitz; Arun J Sanyal; Carleton T Garrett; Maria De Medina; Eugene R Schiff
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.
The American journal of gastroenterology 2003;98(5):1159-66.
2003: Jose R Nery; Caio Nery-Avila; K Rajender Reddy; Robert E Cirocco; Debbie Weppler; David M Levi; Seigo Nishida; Juan Madariaga; Tomoaki Kato; Phillip Ruiz; Eugene R Schiff; Andreas G Tzakis
Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
Transplantation 2003;75(8):1179-86.
2003: Arun J Sanyal; Chris Genning; K Rajender Reddy; Florence Wong; Kris V Kowdley; Kent Benner; Timothy M McCashland
The North American Study for the Treatment of Refractory Ascites.
Gastroenterology 2003;124(3):634-41.
2003: Umaprasanna S Karnam; K Rajender Reddy
Pegylated interferons.
Clinics in liver disease 2003;7(1):139-48.
2003: S Sailaja; K Rajender Reddy; Melath V Rajasekharan; Christelle Hureau; Eric Rivière; Joan Cano; Jean-Jacques Girerd
Synthesis, structure, and magnetic properties of [MnIII(salpn)NCS]n, a helical polymer, and the dimer [MnIII(salpn)NCS]2. Weak ferromagnetism in [MnIII(salpn)NCS]n related to the strong magnetic anisotropy in Jahn-Teller MnIII (salpnH2 = N,N'-bis(salicylidene)-1,3-diaminopropane).
Inorganic chemistry 2003;42(1):180-6.
2002: Arie Regev; Mariana Berho; Lennox Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
The American journal of gastroenterology 2002;97(10):2614-8.
2002: Samuel S Lee; E Jenny Heathcote; K Rajender Reddy; Stefan Zeuzem; Michael W Fried; Teresa L Wright; Paul J Pockros; Dieter Häussinger; Coleman I Smith; Amy Lin; Stephen C Pappas
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).
Journal of hepatology 2002;37(4):500-6.
2002: Michael W Fried; Mitchell L Shiffman; K Rajender Reddy; Coleman Smith; George Marinos; Fernando L Gonçales; Dieter Häussinger; Moisés Diago; Giampiero Carosi; Daniel Dhumeaux; Antonio Craxi; Amy Lin; Joseph Hoffman; Jian Yu
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
The New England journal of medicine 2002;347(13):975-82.
2002: David D Kaplan; K Rajender Reddy
One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
The American journal of gastroenterology 2002;97(9):2465-7.
2002: Jennifer E Layden; Thomas J Layden; K Rajender Reddy; Rachel S Levy-Drummer; Jennifer Poulakos; Avidan U Neumann
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline.
Journal of viral hepatitis 2002;9(5):340-5.
2002: Thomas J Layden; Jennifer E Layden; K Rajender Reddy; Rachel S Levy-Drummer; Jennifer Poulakos; Avidan U Neumann
Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis C.
Journal of viral hepatitis 2002;9(5):334-9.
2002: Guy W Neff; Christopher B O'Brien; K Rajender Reddy; Nora V Bergasa; Arie Regev; Enrique Molina; Rafael Amaro; Miguel J Rodriguez; VeEtta Chase; Lennox Jeffers; Eugene R Schiff
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.
The American journal of gastroenterology 2002;97(8):2117-9.
2002: Abhasnee Sobhonslidsuk; Guy W Neff; Enrique G Molina; Noriyo Yamashiki; Seigo Nishida; K Rajender Reddy; Andreas G Tzakis; Eugene R Schiff
Prediction of survival outcome of ICU patients awaiting orthotopic liver transplantation.
Transplantation proceedings 2002;34(4):1223-5.
2002: Barbara A Piasecki; K Rajender Reddy; Kyong-Mi Chang
Acute hepatitis C: to treat or not to treat?
Hepatology (Baltimore, Md.) 2002;35(6):1538-40.
2002: Abhasnee Sobhonslidsuk; K Rajender Reddy
Portal vein thrombosis: a concise review.
The American journal of gastroenterology 2002;97(3):535-41.
2002: Umaprasanna S Karnam; Colm O'Loughlin; K Rajender Reddy
Bleeding gastric varices: stick to the sticky glue.
The American journal of gastroenterology 2002;97(1):199-200.
2001: E Molina; K Rajender Reddy
Noncirrhotic portal hypertension.
Clinics in liver disease 2001;5(3):769-87.
2001: Umaprasanna S Karnam; I Jaca; K Rajender Reddy
Peginterferon is here to stay.
The American journal of gastroenterology 2001;96(5):1637-8.
2001: Nikolaos Pyrsopoulos; K Rajender Reddy
Extrahepatic manifestations of chronic viral hepatitis.
Current gastroenterology reports 2001;3(1):71-8.
2001: K Rajender Reddy; Teresa L Wright; Paul J Pockros; Mitchell Shiffman; G Everson; Robert W Reindollar; Michael W Fried; P P Purdum; D Jensen; C Smith; W M Lee; T D Boyer; A Lin; S Pedder; J DePamphilis
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;33(2):433-8.
2000: Michael W Fried; Mitchell Shiffman; Richard K Sterling; Jeffrey Weinstein; Jeffrey S Crippin; G Garcia; Teresa L Wright; Hari S Conjeevaram; K Rajender Reddy; J Peter; George Cotsonis; Frederick S. Nolte
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.
The American journal of gastroenterology 2000;95(11):3225-9.
1999: Enrique G Molina; K Rajender Reddy
Postoperative jaundice.
Clinics in liver disease 1999;3(3):477-88.
1999: X Li; Lennox Jeffers; CF Garon; E R Fischer; J Scheffel; B Moore; K Rajender Reddy; M Demedina; Eugene R Schiff
Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line.
Journal of viral hepatitis 1999;6(2):107-14.
1999: Jose R Nery; Debbie Weppler; R Lavandera; Caio Nery-Avila; A Magill; M Rodriguez; K Rajender Reddy; Eugene R Schiff; Andreas G Tzakis
Developing strategies for prevention and treatment of recurrent HBV in liver transplantation.
Transplantation proceedings 1999;31(1-2):485-6.
1998: Kia Saeian; K Rajender Reddy
Hepatitis C cirrhosis--not necessarily a terminal disease.
The American journal of gastroenterology 1998;93(8):1386-7.
1998: Arun J Sanyal; K Rajender Reddy
Vegetative infection of transjugular intrahepatic portosystemic shunts.
Gastroenterology 1998;115(1):110-5.